Our perspective on pricing & value

At BeiGene, we are determined to take an innovative approach to drug pricing. Our goal is to bring improved and novel therapies to the greatest number of patients in ways that are fair, conscientious, and responsible.

We believe in:

• Striving to lower the total cost of care
• Pricing our products to provide maximum value vs in-class competitors
• Lowering out-of-pocket costs for patients

Our value story begins with the clinical utility of our products. This value is created in the lab, substantiated in pivotal trials, and validated in the real world. It’s supported both by credible health economics data and by BeiGene’s continued commitment to innovation in oncology.

Investment in clinical trials

BeiGene invests in robust clinical trials, including head-to-head studies aimed at establishing treatment superiority, to provide access decision makers with the clinical evidence they need to make informed decisions.

We continue to expand our clinical trial footprint to advance products across multiple disease states (eg, oncology, hematology, inflammation, and immunology) and indications.